[96a5a0]: / output / allTrials / identified / NCT02473120_identified.json

Download this file

344 lines (344 with data), 13.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
{
"info": {
"nct_id": "NCT02473120",
"official_title": "Determination of ESR1 Mutations by Digital PCR During Aromatase Inhibitor Treatment in Metastatic Breast Cancer",
"inclusion_criteria": "* Woman aged superior to 18 years old\n* Inform consent signed\n* Metastatic breast cancer or loco-regionnaly advanced breast cancer\n* Inoperable\n* With an indication to treat with aromatase inhibitor\n* Treatment with aromatase inhibitors innitiated at the inclusion or at least 6 months before inclusion with a stable disease\n* Without precedent treatment or with treatment by chemotherapy/tamoxifen/faslodex or aromatase inhibitors in a adjuvant treatment and with a time frame of 2 years between last treatment with aromatase inhibitors and metastatic evolution\n* Treatment by aromatase inhibitors alone or in combination with a targeted therapy (trastuzumab +/- pertuzumab, bevacizumab, everolimus)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* No inform consent signed\n* Patient under guardianship, curatorship\n* Psychosocial disorder\n* No affiliated or beneficiary of a social benefit system",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Woman aged superior to 18 years old",
"criterions": [
{
"exact_snippets": "Woman",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "aged superior to 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Inform consent signed",
"criterions": [
{
"exact_snippets": "Inform consent signed",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Metastatic breast cancer or loco-regionnaly advanced breast cancer",
"criterions": [
{
"exact_snippets": "Metastatic breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "metastatic"
}
]
},
{
"exact_snippets": "loco-regionnaly advanced breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "loco-regionally advanced"
}
]
}
]
},
{
"line": "* Inoperable",
"criterions": [
{
"exact_snippets": "Inoperable",
"criterion": "operability",
"requirements": [
{
"requirement_type": "status",
"expected_value": "inoperable"
}
]
}
]
},
{
"line": "* With an indication to treat with aromatase inhibitor",
"criterions": [
{
"exact_snippets": "indication to treat with aromatase inhibitor",
"criterion": "indication for aromatase inhibitor treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Treatment with aromatase inhibitors innitiated at the inclusion or at least 6 months before inclusion with a stable disease",
"criterions": [
{
"exact_snippets": "Treatment with aromatase inhibitors",
"criterion": "aromatase inhibitor treatment",
"requirements": [
{
"requirement_type": "initiation",
"expected_value": "at inclusion or at least 6 months before inclusion"
}
]
},
{
"exact_snippets": "stable disease",
"criterion": "disease stability",
"requirements": [
{
"requirement_type": "status",
"expected_value": "stable"
}
]
}
]
},
{
"line": "* Without precedent treatment or with treatment by chemotherapy/tamoxifen/faslodex or aromatase inhibitors in a adjuvant treatment and with a time frame of 2 years between last treatment with aromatase inhibitors and metastatic evolution",
"criterions": [
{
"exact_snippets": "Without precedent treatment",
"criterion": "precedent treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "treatment by chemotherapy/tamoxifen/faslodex or aromatase inhibitors in a adjuvant treatment",
"criterion": "adjuvant treatment",
"requirements": [
{
"requirement_type": "treatment type",
"expected_value": [
"chemotherapy",
"tamoxifen",
"faslodex",
"aromatase inhibitors"
]
}
]
},
{
"exact_snippets": "time frame of 2 years between last treatment with aromatase inhibitors and metastatic evolution",
"criterion": "time frame between last treatment with aromatase inhibitors and metastatic evolution",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "=",
"value": 2,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Treatment by aromatase inhibitors alone or in combination with a targeted therapy (trastuzumab +/- pertuzumab, bevacizumab, everolimus)",
"criterions": [
{
"exact_snippets": "Treatment by aromatase inhibitors",
"criterion": "treatment",
"requirements": [
{
"requirement_type": "type",
"expected_value": "aromatase inhibitors"
}
]
},
{
"exact_snippets": "in combination with a targeted therapy (trastuzumab +/- pertuzumab, bevacizumab, everolimus)",
"criterion": "combination treatment",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"trastuzumab",
"pertuzumab",
"bevacizumab",
"everolimus"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* No inform consent signed",
"criterions": [
{
"exact_snippets": "No inform consent signed",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient under guardianship, curatorship",
"criterions": [
{
"exact_snippets": "Patient under guardianship",
"criterion": "guardianship",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Patient ... curatorship",
"criterion": "curatorship",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Psychosocial disorder",
"criterions": [
{
"exact_snippets": "Psychosocial disorder",
"criterion": "psychosocial disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No affiliated or beneficiary of a social benefit system",
"criterions": [
{
"exact_snippets": "No affiliated or beneficiary of a social benefit system",
"criterion": "affiliation with social benefit system",
"requirements": [
{
"requirement_type": "affiliation",
"expected_value": false
}
]
},
{
"exact_snippets": "No affiliated or beneficiary of a social benefit system",
"criterion": "beneficiary of a social benefit system",
"requirements": [
{
"requirement_type": "beneficiary status",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}